Golden
Third Rock Ventures

Third Rock Ventures

Third Rock Ventures is a venture capital firm based in Boston, founded in 2007, which invests in biotechnology startups.

Third Rock Ventures is a venture capital firm headquartered in Boston, Massachusetts. The firm was established by Kevin Starr, Mark Levin, and Robert Tepper in 2007. As of July 2019, Third Rock Ventures is managing an active portfolio of 34 companies and has sold off its ownership in 57 companies. The firm specializes in funding companies at the early stage of development, in the field of biotechnology. Third Rock ventures provided venture capital to MyoKardia, a company which focuses on genetic heart diseases, that went public in 2015.

Timeline

October 31, 2016

Third Rock announces $616m Fund IV

Funded Companies

29 Results
Company
Company
Description
Description
Website
Website
Industry
Industry
Location
Location

A biopharmaceutical company that develops nanotherapeutic treatments for ocular diseases and other eye related conditions

A biotechnology company that develops Probodies, proteolytically-activated antibodies to treat cancer.

A biotechnology company developing blood sampling and testing devices. It was founded in 2008 and is located in Medford, Massachusetts. 

A company developing gene therapies for the treatment of genetic diseases and cancer.

Sage Therapeutics is a biopharmaceutical company founded by Douglas Covey and Steven Paul in 2010 and headquartered in Cambridge, Massachusetts focused on the discovery and development of medicines to address central nervous system disorders.

Magenta Therapeutics is a biotechnology company using stem cells to develop cellular therapies for immune and blood-based diseases.

Foundation Medicine is a Cambridge, Massachusetts-based healthcare company.

Neon Therapeutics is a biotechnology company developing immunotherapies for treating cancer.

A biopharmaceutical company developing therapeutics for the treatment of metabolic disorders such as obesity

A biopharmaceutical company dedicated to the development of novel therapeutics in the field of Epigenetics

A company that develops oral enzyme therapeutics for the treatment of metabolic and kidney disorders

A pharmaceutical company developing therapeutics for the treatment of bladder diseases

A biopharmaceutical company that develops antibody-based therapeutics to treat cancer

A company developing protein homeostasis therapies for oncology, immunology, and inflammation cases

A company developing enzyme-based products for the treatmnet of gastrointestinal disorders and rare diseases

A company developing oral protein therapeutics to treat metabolic diseases

A biotechnology company that develops topical treatment for nail fungal infections

A biotechnology company offering platform for therapeutic antibodies discovery

A pharmaceutical company that develops topical eye drops for the treatment of eye diseases

A company focused on developing regenerative medicines for osteoarthritis, fibrosis and metabolic disease

Decibel Therapeutics is a Boston-based company.

REVOLUTION Medicines is a Redwood City, California-based company.

Associated investment funds

3 Results
Investment Fund
Investment Fund
Total offering (USD)
Total offering (USD)
Total sold (USD)
Total sold (USD)
Location
Location
Date signed
Date signed
500,000,000
500,000,000
March 25, 2013
600,000,000
600,000,000
November 2, 2016
400,000,000
April 9, 2010

People

Name
Role
LinkedIn

Agnieszka Czechowicz

Advisor



Alice Jacobs

Employee



Chris Varma

Employee



Craig Muir

Partner, Cheif Technology Officer



Daniel Poscover

Employee



Elizabeth Kwo, MD

Employee



Emily Duff

Employee



Hana Bauguess

Employee



Ivan Hyep

Employee



Kevin Gillis

Partner, CFO



Michelle Gonzalez

Employee



Richard Cammett

Employee



Sarah Larson

Partner, Chief Human Resources Officer



Walter Kowtoniuk

Employee



Further reading

Title
Author
Link
Type
Date









Documentaries, videos and podcasts

Title
Date
Link





Companies

Company
CEO
Location
Products/Services

Ablexis







Afferent







Agios

























Ambys Medicines

























Cedilla Therapeutics







Celsius







Cibiem







Corvia Medical













Decibel Therapeutics







Edimer













Element Science



















Fulcrum Therapeutics







GBT







Goldfinch Bio







References